Neoadjuvant Chemotherapy for Pancreatic Cancer: Quality over Quantity.

Sam Z ThaljiM AldakkakKk ChristiansCallisia N ClarkeB GeorgeM KamgarBa EricksonWa HallP ChisholmN KulkarniS DoucetteDb EvansSusan Tsai

Published in: Journal of surgical oncology (2023)

CA19-9 normalization after NACT is a clinically significant endpoint of treatment; patients without CA19-9 normalization may benefit from additional therapy. This article is protected by copyright. All rights reserved.

Keyphrases

neoadjuvant chemotherapy
end stage renal disease
ejection fraction
newly diagnosed
locally advanced
chronic kidney disease
lymph node
sentinel lymph node
peritoneal dialysis
stem cells
bone marrow
radiation therapy